HEADER TRANSFERASE 29-OCT-04 1XW5 TITLE HUMAN GLUTATHIONE S-TRANSFERASE M2-2 (E.C.2.5.1.18)COMPLEXED WITH TITLE 2 GLUTATHIONE, MONOCLINIC CRYSTAL FORM COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTATHIONE S-TRANSFERASE MU 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GSTM2-2, GST CLASS-MU 2; COMPND 5 EC: 2.5.1.18; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GSTM2, GST4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PET3A; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET3A-HGSTM2 KEYWDS TRANSFERASE, GLUTATHIONE, CONJUGATION, DETOXIFICATION, CYTOSOLIC, KEYWDS 2 DIMER, ACTIVE SITE EXPDTA X-RAY DIFFRACTION AUTHOR L.N.PATSKOVSKA,Y.V.PATSKOVSKY,S.C.ALMO,I.LISTOWSKY REVDAT 4 11-OCT-17 1XW5 1 REMARK REVDAT 3 24-FEB-09 1XW5 1 VERSN REVDAT 2 15-FEB-05 1XW5 1 TITLE REVDAT 1 30-NOV-04 1XW5 0 JRNL AUTH Y.PATSKOVSKY,L.N.PATSKOVSKA,S.C.ALMO,I.LISTOWSKY JRNL TITL STRUCTURAL PERTURBATION OF THE ACTIVE SITE OF HUMAN JRNL TITL 2 GLUTATHIONE-S-TRANSFERASE M2-2 UPON LIGAND BINDING JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH L.N.PATSKOVSKA,A.A.FEDOROV,Y.V.PATSKOVSKY,S.C.ALMO, REMARK 1 AUTH 2 I.LISTOWSKY REMARK 1 TITL EXPRESSION, CRYSTALLIZATION AND PRELIMINARY X-RAY ANALYSIS REMARK 1 TITL 2 OF LIGAND-FREE HUMAN GLUTATHIONE S-TRANSFERASE M2-2 REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 54 458 1998 REMARK 1 REFN ISSN 0907-4449 REMARK 1 REFERENCE 2 REMARK 1 AUTH S.RAGHUNATHAN,R.J.CHANDROSS,R.H.KRETSINGER,T.J.ALLISON, REMARK 1 AUTH 2 C.J.PENINGTON,G.S.RULE REMARK 1 TITL CRYSTAL STRUCTURE OF HUMAN CLASS MU GLUTATHIONE TRANSFERASE REMARK 1 TITL 2 GSTM2-2. EFFECTS OF LATTICE PACKING ON CONFORMATIONAL REMARK 1 TITL 3 HETEROGENEITY REMARK 1 REF J.MOL.BIOL. V. 238 815 1994 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 3 REMARK 1 AUTH W.R.VORACHEK,W.R.PEARSON,G.S.RULE REMARK 1 TITL CLONING, EXPRESSION, AND CHARACTERIZATION OF A CLASS-MU REMARK 1 TITL 2 GLUTATHIONE TRANSFERASE FROM HUMAN MUSCLE, THE PRODUCT OF REMARK 1 TITL 3 THE GST4 LOCUS REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 88 4443 1991 REMARK 1 REFN ISSN 0027-8424 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.1000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 88.6 REMARK 3 NUMBER OF REFLECTIONS : 38283 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1160 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.91 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 50.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3491 REMARK 3 BIN R VALUE (WORKING SET) : 0.2800 REMARK 3 BIN FREE R VALUE : 0.3110 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 2.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 99 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.031 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3614 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 461 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.41000 REMARK 3 B22 (A**2) : 4.85000 REMARK 3 B33 (A**2) : -0.45000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.29000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM SIGMAA (A) : 0.20 REMARK 3 LOW RESOLUTION CUTOFF (A) : 6.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.23 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.240 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.860 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.290 ; 3.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.590 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.640 ; 4.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 25.41 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN.PARAM REMARK 3 PARAMETER FILE 2 : WATER.PARAM REMARK 3 PARAMETER FILE 3 : GSHPARAM.PEP REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : GSHTOP.PEP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1XW5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-NOV-04. REMARK 100 THE DEPOSITION ID IS D_1000030834. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-OCT-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE CRYSTAL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38664 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.3 REMARK 200 DATA REDUNDANCY : 7.700 REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : 0.06200 REMARK 200 FOR THE DATA SET : 11.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 43.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : 0.01700 REMARK 200 R SYM FOR SHELL (I) : 0.01900 REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CCP4 REMARK 200 STARTING MODEL: PDB ENTRY 2GTU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG4000, PH 6.50, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 24.89500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL UNIT IS A HOMODIMER, THE ASSYMETRIC UNIT REMARK 300 CONTAINS HOMODIMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18810 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 71 106.58 75.18 REMARK 500 PRO B 57 122.31 -36.77 REMARK 500 GLN B 71 103.54 79.67 REMARK 500 LEU B 85 41.09 -109.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GSH A 471 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GSH B 472 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2GTU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF LIGAND-FREE HUMAN GLUTATHIONE-S-TRANSFERASE M2- REMARK 900 2 REMARK 900 RELATED ID: 1HNA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN GLUTATHIONE-S-TRANSFERASE M2-2 REMARK 900 (TRP214PHE MUTANT) DBREF 1XW5 A 1 217 UNP P28161 GSTM2_HUMAN 1 217 DBREF 1XW5 B 1 217 UNP P28161 GSTM2_HUMAN 1 217 SEQRES 1 A 217 PRO MET THR LEU GLY TYR TRP ASN ILE ARG GLY LEU ALA SEQRES 2 A 217 HIS SER ILE ARG LEU LEU LEU GLU TYR THR ASP SER SER SEQRES 3 A 217 TYR GLU GLU LYS LYS TYR THR MET GLY ASP ALA PRO ASP SEQRES 4 A 217 TYR ASP ARG SER GLN TRP LEU ASN GLU LYS PHE LYS LEU SEQRES 5 A 217 GLY LEU ASP PHE PRO ASN LEU PRO TYR LEU ILE ASP GLY SEQRES 6 A 217 THR HIS LYS ILE THR GLN SER ASN ALA ILE LEU ARG TYR SEQRES 7 A 217 ILE ALA ARG LYS HIS ASN LEU CYS GLY GLU SER GLU LYS SEQRES 8 A 217 GLU GLN ILE ARG GLU ASP ILE LEU GLU ASN GLN PHE MET SEQRES 9 A 217 ASP SER ARG MET GLN LEU ALA LYS LEU CYS TYR ASP PRO SEQRES 10 A 217 ASP PHE GLU LYS LEU LYS PRO GLU TYR LEU GLN ALA LEU SEQRES 11 A 217 PRO GLU MET LEU LYS LEU TYR SER GLN PHE LEU GLY LYS SEQRES 12 A 217 GLN PRO TRP PHE LEU GLY ASP LYS ILE THR PHE VAL ASP SEQRES 13 A 217 PHE ILE ALA TYR ASP VAL LEU GLU ARG ASN GLN VAL PHE SEQRES 14 A 217 GLU PRO SER CYS LEU ASP ALA PHE PRO ASN LEU LYS ASP SEQRES 15 A 217 PHE ILE SER ARG PHE GLU GLY LEU GLU LYS ILE SER ALA SEQRES 16 A 217 TYR MET LYS SER SER ARG PHE LEU PRO ARG PRO VAL PHE SEQRES 17 A 217 THR LYS MET ALA VAL TRP GLY ASN LYS SEQRES 1 B 217 PRO MET THR LEU GLY TYR TRP ASN ILE ARG GLY LEU ALA SEQRES 2 B 217 HIS SER ILE ARG LEU LEU LEU GLU TYR THR ASP SER SER SEQRES 3 B 217 TYR GLU GLU LYS LYS TYR THR MET GLY ASP ALA PRO ASP SEQRES 4 B 217 TYR ASP ARG SER GLN TRP LEU ASN GLU LYS PHE LYS LEU SEQRES 5 B 217 GLY LEU ASP PHE PRO ASN LEU PRO TYR LEU ILE ASP GLY SEQRES 6 B 217 THR HIS LYS ILE THR GLN SER ASN ALA ILE LEU ARG TYR SEQRES 7 B 217 ILE ALA ARG LYS HIS ASN LEU CYS GLY GLU SER GLU LYS SEQRES 8 B 217 GLU GLN ILE ARG GLU ASP ILE LEU GLU ASN GLN PHE MET SEQRES 9 B 217 ASP SER ARG MET GLN LEU ALA LYS LEU CYS TYR ASP PRO SEQRES 10 B 217 ASP PHE GLU LYS LEU LYS PRO GLU TYR LEU GLN ALA LEU SEQRES 11 B 217 PRO GLU MET LEU LYS LEU TYR SER GLN PHE LEU GLY LYS SEQRES 12 B 217 GLN PRO TRP PHE LEU GLY ASP LYS ILE THR PHE VAL ASP SEQRES 13 B 217 PHE ILE ALA TYR ASP VAL LEU GLU ARG ASN GLN VAL PHE SEQRES 14 B 217 GLU PRO SER CYS LEU ASP ALA PHE PRO ASN LEU LYS ASP SEQRES 15 B 217 PHE ILE SER ARG PHE GLU GLY LEU GLU LYS ILE SER ALA SEQRES 16 B 217 TYR MET LYS SER SER ARG PHE LEU PRO ARG PRO VAL PHE SEQRES 17 B 217 THR LYS MET ALA VAL TRP GLY ASN LYS HET GSH A 471 20 HET GSH B 472 20 HETNAM GSH GLUTATHIONE FORMUL 3 GSH 2(C10 H17 N3 O6 S) FORMUL 5 HOH *461(H2 O) HELIX 1 1 ARG A 10 LEU A 12 5 3 HELIX 2 2 ALA A 13 THR A 23 1 11 HELIX 3 3 ARG A 42 ASN A 47 1 6 HELIX 4 4 GLU A 48 LEU A 52 5 5 HELIX 5 5 GLN A 71 LYS A 82 1 12 HELIX 6 6 SER A 89 TYR A 115 1 27 HELIX 7 7 ASP A 118 GLY A 142 1 25 HELIX 8 8 THR A 153 GLU A 170 1 18 HELIX 9 9 PHE A 177 GLY A 189 1 13 HELIX 10 10 LEU A 190 LYS A 198 1 9 HELIX 11 11 ARG B 10 LEU B 12 5 3 HELIX 12 12 ALA B 13 THR B 23 1 11 HELIX 13 13 ARG B 42 ASN B 47 1 6 HELIX 14 14 GLU B 48 LEU B 52 5 5 HELIX 15 15 GLN B 71 HIS B 83 1 13 HELIX 16 16 SER B 89 TYR B 115 1 27 HELIX 17 17 ASP B 118 GLY B 142 1 25 HELIX 18 18 THR B 153 GLU B 170 1 18 HELIX 19 19 PHE B 177 LEU B 190 1 14 HELIX 20 20 LEU B 190 SER B 199 1 10 SHEET 1 A 4 TYR A 27 TYR A 32 0 SHEET 2 A 4 MET A 2 TRP A 7 1 N LEU A 4 O GLU A 28 SHEET 3 A 4 TYR A 61 ASP A 64 -1 O ILE A 63 N THR A 3 SHEET 4 A 4 HIS A 67 THR A 70 -1 O ILE A 69 N LEU A 62 SHEET 1 B 4 TYR B 27 TYR B 32 0 SHEET 2 B 4 MET B 2 TRP B 7 1 N MET B 2 O GLU B 28 SHEET 3 B 4 TYR B 61 ASP B 64 -1 O ILE B 63 N THR B 3 SHEET 4 B 4 HIS B 67 THR B 70 -1 O HIS B 67 N ASP B 64 CISPEP 1 ALA A 37 PRO A 38 0 -0.16 CISPEP 2 LEU A 59 PRO A 60 0 0.11 CISPEP 3 ARG A 205 PRO A 206 0 -0.39 CISPEP 4 ALA B 37 PRO B 38 0 0.05 CISPEP 5 LEU B 59 PRO B 60 0 0.10 CISPEP 6 ARG B 205 PRO B 206 0 -0.25 SITE 1 AC1 18 TYR A 6 TRP A 7 LEU A 12 ARG A 42 SITE 2 AC1 18 TRP A 45 LYS A 49 ASN A 58 LEU A 59 SITE 3 AC1 18 PRO A 60 GLN A 71 SER A 72 HOH A 482 SITE 4 AC1 18 HOH A 533 HOH A 548 HOH A 558 HOH A 575 SITE 5 AC1 18 HOH A 693 ASP B 105 SITE 1 AC2 19 ASP A 105 TYR B 6 TRP B 7 LEU B 12 SITE 2 AC2 19 ARG B 42 TRP B 45 LYS B 49 ASN B 58 SITE 3 AC2 19 LEU B 59 PRO B 60 GLN B 71 SER B 72 SITE 4 AC2 19 HOH B 477 HOH B 492 HOH B 504 HOH B 623 SITE 5 AC2 19 HOH B 664 HOH B 665 HOH B 667 CRYST1 51.200 49.790 92.040 90.00 94.27 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019531 0.000000 0.001458 0.00000 SCALE2 0.000000 0.020084 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010895 0.00000 MASTER 274 0 2 20 8 0 10 6 0 0 0 34 END